In contrast, in PTC, N-cadherin not only promotes tumor growth by facilitating the Epithelial-Mesenchymal Transition (EMT) process but is also closely associated with the activation of the MAPK/ERK, PI3K/AKT, and p16/Rb signaling pathways. Here, CDH2 is linked to neoplasm.